New Study Shows Data on Cancer Survivors’ Cannabis Use, Effectiveness as Treatment

New Study Shows Data on Cancer Survivors’ Cannabis Use, Effectiveness as Treatment

In a recently published study, Cancer Survivorship Journal We found evidence that the majority of participants who were cancer survivors used cannabis to manage symptoms.

of study The paper was co-authored by four researchers with funding from the National Cancer Institute, the Betty B. Marcus Chair in Cancer Prevention, and the Duncan Family Institute for Cancer Prevention and Risk Assessment. Ta. Analyzing a total of 1,886 participants, 17.4% said they currently consumed cannabis, 30.5% described themselves as “former” consumers, and 52.2% said they had ever used cannabis. I answered that there was no. Current or former consumers (approximately 510 participants) reported that using cannabis caused “disordered sleep (60%), pain (51%), stress (44%), and nausea (34%).” He said it had been alleviated. Mood disorders/depression (32%). Furthermore, one-fifth (91 people) of the 510 participants used cannabis specifically to treat cancer, and half of the 510 participants who used cannabis to treat a specific symptom said, “It helped me a lot to improve.”

Of the participants, negative side effects included “suicidal thoughts (5%), severe nausea and vomiting (6%), depression (11%), anxiety (14%), difficulty breathing (31%), and interaction.” Only 167 people said they had experienced it. Concomitant use of anticancer drugs (35%).”

Ultimately, participants found that cannabis was therapeutic. For example, of those who used cannabis to treat nausea, 73.6% said it was “quite a bit” effective, but only 24.4% said it was “very marginally” effective. , 1.9% said it had no effect at all. Overall, half of the participants said cannabis had a “very good effect,” less than half said it had a “somewhat good effect,” and only about 5% said it had little effect. Ta.

Similar results were shown for the proportion of participants who used . cannabis for cancer treatment. The researchers found that 47.7% of participants felt that cannabis was “quite” effective for treatment, 34.5% said it was “somewhat” effective, and 13.8% said it was “not very effective.” Only 4% said it was “effective.” It didn't help at all.

The researchers also noted that most participants were unaware of the potential health risks of cannabis during treatment. “Only a few people were aware of the health risks of using cannabis during cancer treatment.” written by researchers. “Of the 167 survivors who reported awareness of potential health risks from cannabis use, awareness of the negative health effects associated with cannabis use was low, including suicidal thoughts (5%) and severe nausea and vomiting (6%). , depression (11%), anxiety (14%), breathing problems (31%), and interactions with cancer drugs (35%).

Given this data, the researchers added the need for further research. “Further research is needed to strengthen the current evidence regarding cannabis treatment, as most survivors report benefits of cannabis use in cancer treatment.” the researcher wrote. “We also need policies, clear guidelines, and cannabis-based education programs for healthcare professionals and survivors about the use, benefits, and risks of cannabis in cancer management.”

The researchers also explained the importance of discussing cannabis treatment with health care providers, stating, ' was also explained.

A NORML report released in late December found that 32,000 peer-reviewed scientific research papers and reports have been published since 2013. Additionally, NORML stated that documented cannabis research has been going on since the 19th century. “At the time of writing this article, NORML cites more than 45,900 scientific papers on marijuana dating back to 1840. PubMed, which has been publicly available online since 1996, is a free resource that supports search and retrieval of biomedical and life sciences literature.

Based on this information, NORML Deputy Director Paul Armentano refuted those who claim there is not enough evidence that cannabis is effective as a treatment for many conditions. “Despite some claims that marijuana has not yet received sufficient scientific scrutiny, scientists' interest in cannabis research has sharply increased in recent years, and research on the cannabis plant, its active ingredients, its mechanisms of action, and our understanding of its effects, both for users and for society,” Armentano said. “Politicians and others need to stop evaluating cannabis through the lens of 'what we don't know,' and instead focus on the evidence about marijuana and marijuana reform policy that shows everything we know. It’s time to start engaging in discussions based on .”

Meanwhile, the number of research papers stating the effectiveness of cannabis for cancer patients continues to grow. In early 2023, a study conducted by researchers in the United States, Canada, and Ireland found that cannabis is a safe and effective way to treat cancer pain. The end of last year, university at buffalo Researchers announced they have received a $3.2 million grant from the National Cancer Institute to study how cannabis affects cancer patients receiving immunotherapy. Other psychedelics have also been studied in relation to cancer, such as an October 2023 study that showed how psilocybin and MDMA can help treat anxiety in cancer patients.

David B.
David B. stands out as an exceptional cannabis writer, skillfully navigating the intricate world of cannabis culture and industry. His insightful and well-researched articles provide a nuanced perspective on various aspects, from the therapeutic benefits to the evolving legal landscape. David's writing reflects a deep understanding of the plant's history, its diverse strains, and the ever-changing dynamics within the cannabis community. What sets him apart is his ability to break down complex topics into digestible pieces, making the information accessible to both seasoned enthusiasts and newcomers alike. With a keen eye for detail and a passion for the subject, David B. emerges as a reliable and engaging voice in the realm of cannabis literature.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *